Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer

NISHINA, Takuya

doi:10.1007/s12282-025-01768-6

ID	70696
Title Alternative	13,284人に対するCDK4/6阻害薬のSwitch投与に関するリアルワールドデータ
FullText URL	K0007568_abstract_review.pdf 384 KB K0007568_fulltext.pdf 2.4 MB K0007568_other.pdf 403 KB
Author	NISHINA, Takuya Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Note	岡山大学審査学位論文 Nishina, T., Tanioka, M., Takada, K. et al. Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer. Breast Cancer 32, 1405–1416 (2025). https://doi.org/10.1007/s12282-025-01768-6
Published Date	2026-03-25
Content Type	Thesis or Dissertation
Grant Number	甲第7568号
Granted Date	2026-03-25
Thesis Type	Doctor of Philosophy in Medical Science
Grantor	岡山大学
Thesis FullText	Thesis or Dissertation (See FullText URL)
Related Url	isVersionOf https://doi.org/10.1007/s12282-025-01768-6
language	English
File Version	ETD
Grant ID	15301甲第7568号
PubMed ID	41076600
Copyright Holders	© The Author(s) 2025
DOI	10.1007/s12282-025-01768-6
License	http://creativecommons.org/licenses/by/4.0/